Results

Total Results: 1,017 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. hcup-us.ahrq.gov/datainnovations/raceethnicitytoolkit/about_grants_re.jsp
    July 01, 2016 - Patient-Centered Outcomes Research Institute (PCORI) Investigator : Romana Hasnain-Wynia  Cancer … Investigators : Scarlett Lin Gomez Sally Glaser Daphne Lichtensztajn Laura Allen Los Angeles County Cancer … Statistics and Background Reports on Disparities Cancer among American Indians and Alaska Natives in … Idaho, Oregon, and Washington Northwest American Indian and Alaska Native Mortality Cancer among … death in Washington, Idaho, and Oregon BIRTH CERTIFICATE DATA FACT SHEETS: For Idaho and Oregon CANCER
  2. hcup-us.ahrq.gov/reports/spotlights_archive.jsp
    December 01, 2019 - Cancer. 2015 Mar 1;121(5):747-57. … , lung cancer, breast cancer, and melanoma. … Read more about this publication Inpatient survival after gastrectomy for gastric cancer in … Cancer. 2013 Jul 1;119(13):2462-8. doi: 10.1002/cncr.28050. … Pediatr Blood Cancer. 2012 Oct;59(4):685-9.
  3. hcup-us.ahrq.gov/reports/natstats/commdx/commdx.htm
    October 01, 1999 - Whittle, Steinberg, Anderson et al. ( 1991 ) reported that estimates of cancer incidence rates based … on Medicare claims data were within 6 percent of estimates using the National Cancer Institute's Surveillance … For example, in Table 1, the ninth ranked procedure (P9), hysterectomy, is performed for benign neoplasmCancer of the prostate, which was 60th in 1992, ranked 81st 4 years later. … Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly
  4. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
    January 01, 2012 - electrolyte disorders 13,459,216 0 0.00 1.00 0.21 0.41 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,459,216 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,811 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 7,576 0.06% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 9,897 0.07% 690 … 18,144 0.13% 692: Radiotherapy 1,115 0.01% 693: Chemotherapy 58,907 0.44% 694: Lymphatic & other malignancies
  5. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
    January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13% 692: Radiotherapy 1,207 0.01% 693: Chemotherapy 61,609 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09% 710: Infectious & parasitic diseases including HIV w
  6. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
    January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14% 692: Radiotherapy 1,534 0.01% 693: Chemotherapy 61,552 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09% 710: Infectious & parasitic diseases including HIV w
  7. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
    January 01, 2013 - electrolyte disorders 14,325,172 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,325,172 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,987 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,114 0.01% 693: Chemotherapy 62,706 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,072 0.08% 710: Infectious & parasitic diseases including HIV w
  8. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
    January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06% 690 … & neoplasms of uncertain behavior 6,509 0.08% 710: Infectious & parasitic diseases including HIV w
  9. hcup-us.ahrq.gov/db/nation/nis/tools/stats/FileSpecifications_NIS_2008_Severity.TXT
    January 01, 2008 - Severity 27 CM_METS 97 98 Num AHRQ comorbidity measure: Metastatic cancer … 2008 Severity 35 CM_TUMOR 113 114 Num AHRQ comorbidity measure: Solid tumor
  10. hcup-us.ahrq.gov/db/nation/nis/tools/stats/FileSpecifications_NIS_2009_Severity.TXT
    January 01, 2009 - Severity 27 CM_METS 97 98 Num AHRQ comorbidity measure: Metastatic cancer … 2009 Severity 35 CM_TUMOR 113 114 Num AHRQ comorbidity measure: Solid tumor
  11. hcup-us.ahrq.gov/db/nation/kid/tools/stats/FileSpecifications_KID_2009_Severity.TXT
    January 01, 2009 - Severity 27 CM_METS 91 92 Num AHRQ comorbidity measure: Metastatic cancer … 2009 Severity 35 CM_TUMOR 107 108 Num AHRQ comorbidity measure: Solid tumor
  12. hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-User-Guide-v2025-1.pdf
    November 01, 2024 - • Removed C80.1, Malignant (primary) neoplasm, unspecified, and R180, Malignant ascites, as these … are not indicative of metastatic cancer. … • Focused this measure on solid malignant tumors without metastasis, starting with v2021.1. … • Added diagnosis codes that align with the National Cancer Institute’s classification of cancer … Additionally, added diagnosis codes indicative of cancers of the skin.
  13. hcup-us.ahrq.gov/toolssoftware/comorbidity/comoanaly_01.txt
    December 08, 2004 - DM DMCX HYPOTHY RENLFAIL LIVER ULCER AIDS LYMPH METS TUMOR … **********************************************/ IF HTNCX = 1 THEN HTN = 0 ; IF METS = 1 THEN TUMOR … AND CANCFLG THEN TUMOR = 0; IF ARTH AND ARTHFLG THEN ARTH = 0; IF COAG AND DRG = 397 THEN COAG … immune deficiency syndrome' LYMPH = 'Lymphoma' METS = 'Metastatic cancer … ' TUMOR = 'Solid tumor w/out metastasis' ARTH = 'Rheumatoid arthritis
  14. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
    January 01, 2014 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,071,762 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06% 690 … Percent of Total 692: Radiotherapy 586 0.01% 693: Chemotherapy 29,695 0.42% 694: Lymphatic & other malignancies
  15. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
    November 08, 2017 - electrolyte disorders 5,377,720 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06% 690 … & neoplasms of uncertain behavior 3,745 0.07% 710: Infectious & parasitic diseases including HIV w
  16. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
    January 01, 2013 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,119,563 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06% 690 … Percent of Total 692: Radiotherapy 664 0.01% 693: Chemotherapy 30,425 0.43% 694: Lymphatic & other malignancies
  17. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
    January 01, 2012 - electrolyte disorders 3,195,782 0 0.00 1.00 0.08 0.27 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15% 110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG APRDRG Frequency Percent of Total 693: Chemotherapy 32,305 1.01% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01% 710: Infectious & parasitic diseases including HIV w O.R
  18. hcup-us.ahrq.gov/reports/methods/2010_03.pdf
    January 01, 2010 - of head and neck 32 (3) 29 (3) 7.67 (0.19) 6.221 (c) 3.77 (0.39) 6.591 (c) 12: Cancer of … of rectum and anus 47 (2) 37* (3) 8.58 (0.11) 7.881 (c) 3.08 (0.21) 3.571 (c) 16: Cancer … of uterus 41 (2) 30* (3) 4.19 (0.10) 4.151 (c) 1.26 (0.14) 1.351 (c) 26: Cancer of cervix … 23 (1) 20 (2) 3.55 (0.09) 3.661 (c) 1.60 (0.18) 0.791 (c) 27: Cancer of ovary 25 (1) 25 (3) … 6.76 (0.15) 6.001 (c) 4.48 (0.38) 3.971 (c) 30: Cancer of testis 2 (0) --1 (a) 6.31 (0.39
  19. hcup-us.ahrq.gov/db/nation/nis/reports/2007niscomparisonrpt.jsp
    May 01, 2016 - of uterus 41 (2) 30* (3) 4.19 (0.10) 4.15 1 (c) 1.26 (0.14) 1.35 1 (c) 26: Cancer … of cervix 23 (1) 20 (2) 3.55 (0.09) 3.66 1 (c) 1.60 (0.18) 0.79 1 (c) 27: Cancer … of ovary 25 (1) 25 (3) 6.76 (0.15) 6.00 1 (c) 4.48 (0.38) 3.97 1 (c) 30: Cancer … of testis 2 (0) -- 1 (a) 6.31 (0.39) -- 1 (a) 2.38 (0.79) -- 1 (a) 32: Cancer of … bladder 38 (2) 34 (3) 6.23 (0.18) 5.48 1 (c) 3.13 (0.22) 1.79 1 (c) 35: Cancer
  20. hcup-us.ahrq.gov/reports/statbriefs/sb82.pdf
    December 01, 2009 - ■ Increases in cost per stay contributed notably to the growth of aggregate costs of stays for cancer … HCUP data include OB-GYN, ENT, orthopedic, cancer, pediatric, public, and academic medical hospitals … 88,500 68.6% 40.8% Aortic resection; replacement or anastomosis $1,872,908,000 61,600 38.5% 31.9% Cancer … $93,480,000 (5.0%) 63.6% 34.4% $402,210,000 (21.5%) 37.8% 34.2% $38,269,000 (2.0%) 64.0% 113.4% Cancer … drainage of skin ($1.1 billion) Lobectomy or pneumonectomy ($1.8 billion) Spinal fusion ($8.9 billion) Cancer

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: